Real‐world pharmacovigilance assessment of drug‐induced male hypogonadism risks: An analysis of FDA adverse drug event data
This research summarized a list of potential drugs associated with hypogonadism. A clear understanding of the risk and frequency of drug-induced hypogonadism can reduce the likelihood of patients developing the condition.
Authors
- Xiaoming Cao (ORCID: https://orcid.org/0000-0002-3306-3468)
- Jing Zhang (ORCID: https://orcid.org/0000-0003-1513-0695)
- Yijun Jia (ORCID: https://orcid.org/0000-0001-7044-1897)
- Yujia Xi (ORCID: https://orcid.org/0000-0002-2590-2428)
- Zhenzhong Zheng (ORCID: https://orcid.org/0000-0001-9239-3996)
- Jingqi Wang (ORCID: https://orcid.org/0000-0003-2820-1026)
Institutions
- Shanxi Medical University (CN)
- Second Hospital of Shanxi Medical University (CN)
- Shanxi Academy of Medical Sciences (CN)
Publication Details
- Journal
- Andrology
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1111/andr.70120
- Primary Topic
- Hormonal and reproductive studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Shanxi Province
- ShanXi Science and Technology Department
- Wu Jieping Medical Foundation